This seems to me more than just coincidence considering the profile of product pipelines and therapeutic areas both companies bet on.
I was watching both for some time and placed a position to
ABBV before earnings @ major support level, which was broken and then turned.
Major support @ 468 (50% monthly Fib level)
Potential upside to 700 with test of ATH 664.
Very good R/R of 1:7.
Good fundamentals on top of above made
REGN a definitive buy for me as I was waiting a good price to enter.
Discussion purpose only, not an advice.
I was watching both for some time and placed a position to
ABBV before earnings @ major support level, which was broken and then turned. Major support @ 468 (50% monthly Fib level)
Potential upside to 700 with test of ATH 664.
Very good R/R of 1:7.
Good fundamentals on top of above made
REGN a definitive buy for me as I was waiting a good price to enter.Discussion purpose only, not an advice.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.